Cathie Wood's $362 Million CRISPR Bet: Hidden Catalyst
Cathie Wood’s big bet on CRISPR Therapeutics signals more than faith in gene editing. This article digs into the unde...
Knowing what not to do as a new investor can save you time and money. Avoid common mistakes to build a successful investment portfolio.
28,072 articlesCathie Wood’s big bet on CRISPR Therapeutics signals more than faith in gene editing. This article digs into the unde...
Two popular small-cap ETFs, VB and ISCB, offer different advantages. VB shines on costs and liquidity, while ISCB may...
As kontoor brands (ktb) 2025 unfolds, investors are weighing margins, brand strength, and growth channels. This artic...
A biotech stock that sprinted 685% in months drew a sizeable institutional bet as it pressed ahead with two FDA filin...
Shopify delivered strong quarterly results, but the stock traded lower as guidance softened. This article explains wh...
A 10% move in Vericel stock drew attention after a COO sold shares worth $402,000. This article breaks down what the ...
A major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
What did spacex stock close on its inaugural trading day? This article breaks down a hypothetical first-day close, wh...
AutoZone recently missed Wall Street estimates, sending shares lower before stabilizing. This guide breaks down what ...
If the idea of Cathie Wood buying million-dollar stakes catches your eye, you’re not alone. This article breaks down ...
When insider-like conviction meets market risk, funds can double down on a stock. This analysis explains why Black Cy...
Geopolitics can move markets fast. When tensions rise, like with Iran, volatility spikes and portfolios feel the stra...